Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.25259/IJDVL_364_20 http://scihub22266oqcxt.onion/10.25259/IJDVL_364_20 33969653!ä!33969653 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Indian+J+Dermatol+Venereol+Leprol 2021 ; 87 (5): 603-610 Nephropedia Template TP {{tp|p=33969653|t=2021. Dermatology practice in the times of the COVID-19 pandemic |pdf=|usr=}}{{33969653}} gab.com Text Dermatology practice in the times of the COVID-19 pandemic JO: Indian J Dermatol Venereol Leprol http://www.kidney.de/pget.php?&tw=1&pmid=33969653 #FOAvip The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is implicated in the ongoing pandemic across the globe since December 2019. It was first notified by China from Wuhan on 31 December 2020 and transmission to healthcare workers was first reported on 20 January 2020. Human-to-human transmission is mainly by droplet infection. At present no effective vaccine is available. Our speciality needs to collectively address the urgent issue of risk of transmission in dermatology practice. A case series of Coronavirus Disease 2019 (COVID-19) from Wuhan described that 41.3% of their patients may have acquired the infection from the hospital. Of all the infected health care workers, 77.5% worked in general wards and departments. These data highlight the significant risk of nosocomial transmission of COVID-19 and also the higher risk in general wards and departments compared to the emergency room or intensive care unit. Dermatology patients are generally seen in clinics and in outpatient departments in hospitals. Patients wait together in the waiting area, intermingle and then are seen by the physician in their chamber. This can cause transmission of the pathogen among patients and from patient to physician. Social distancing, hand hygiene and the use of personal protective equipment are important for preventing the spread of infection and dermatology practices also have to incorporate these aspects. Telemedicine is becoming an important tool for the management of dermatology patients in these times. At-risk patients in dermatology also need to be given priority care. Protocols for the use of immunosuppressants and biologics in dermatology during the pandemic are being developed. Twit Text FOAVip Dermatology practice in the times of the COVID-19 pandemic ????Indian J Dermatol Venereol Leprol http://www.kidney.de/pget.php?&tw=1&pmid=33969653 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33969653 #FOAvip English Wikipedia <ref>{{Cite pmid|33969653}}</ref> Dermatology practice in the times of the COVID-19 pandemic #MMPMID33969653 Vashisht D; Neema S; Venugopalan R; Pathania V; Sandhu S; Vasudevan B Indian J Dermatol Venereol Leprol 2021[Sep]; 87 (5): 603-610 PMID33969653show ga The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is implicated in the ongoing pandemic across the globe since December 2019. It was first notified by China from Wuhan on 31 December 2020 and transmission to healthcare workers was first reported on 20 January 2020. Human-to-human transmission is mainly by droplet infection. At present no effective vaccine is available. Our speciality needs to collectively address the urgent issue of risk of transmission in dermatology practice. A case series of Coronavirus Disease 2019 (COVID-19) from Wuhan described that 41.3% of their patients may have acquired the infection from the hospital. Of all the infected health care workers, 77.5% worked in general wards and departments. These data highlight the significant risk of nosocomial transmission of COVID-19 and also the higher risk in general wards and departments compared to the emergency room or intensive care unit. Dermatology patients are generally seen in clinics and in outpatient departments in hospitals. Patients wait together in the waiting area, intermingle and then are seen by the physician in their chamber. This can cause transmission of the pathogen among patients and from patient to physician. Social distancing, hand hygiene and the use of personal protective equipment are important for preventing the spread of infection and dermatology practices also have to incorporate these aspects. Telemedicine is becoming an important tool for the management of dermatology patients in these times. At-risk patients in dermatology also need to be given priority care. Protocols for the use of immunosuppressants and biologics in dermatology during the pandemic are being developed. |Ambulatory Care/methods/organization & administration[MESH] |Biological Products/therapeutic use[MESH] |COVID-19/*prevention & control/transmission[MESH] |Cross Infection/*prevention & control/transmission[MESH] |Dermatology/*organization & administration[MESH] |Humans[MESH] |Immunosuppressive Agents/therapeutic use[MESH] |India[MESH] |Risk Factors[MESH] |SARS-CoV-2[MESH] |Skin Diseases/complications/diagnosis/*therapy[MESH] |Telemedicine/legislation & jurisprudence[MESH] |Vaccination[MESH]Dermatology practice in the times of the COVID-19 pandemic (epmc).pdf DeepDyve Pubget Overpricing